Bioriginal acquires softgel manufacturer Softgel Co.
Softgel Co. provides contract manufacturing services for softgels as well as bottling, packaging, and labeling.
Ingredient supplier Bioriginal Food & Science Corp. (Saskatoon, Canada) has acquired Softgel Co. (Grand Junction, CO), a contract manufacturer of softgels. The companies say the Softgel facility plans to double its capacity to accommodate demand for Bioriginal products, including bulk seed and fish oil ingredients. Target markets are the human nutrition and pet nutrition markets.
In addition to manufacturing both vegan and animal softgels, Softgel Co. offers bottling, labeling, and packaging services, as well as squeeze tube and tincture manufacturing.
In a press release, Bioriginal states that Softgel Co.’s 10 years of encapsulation experience as well as its ability to produce over one million softgels per shift makes the acquisition a natural next step for Bioriginal, which aims to control its entire manufacturing process.
“The addition of Softgel expands Bioriginal’s global supply abilities, removing the need to outsource softgel production, improving production efficiencies, and enhancing supply chain management,” stated Shannon Sears, president and CEO of Bioriginal, in the press release.
Sears added: “This level of vertical integration ensures what is on the label is in the bottle. Consumers deserve that level of confidence.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
